Synergy Research Group Joins the European Forum for Good Clinical Practice
Synergy Research Group (SynRG) has become the first Russian member of the European Forum for Good Clinical Practice (EFGCP). Founded in 1993, EFGCP aims to promote Good Clinical Practice and high-quality biomedical research throughout Europe.
“These goals and objectives are very much in line with our own long-term strategies, so we’d be very pleased to join our efforts with EFGCP,” said Igor Stefanov, SynRG General Manager, in a press release.
From the beginning of its membership, SynRG became involved in EFGCP activities and plans on integrating Russia into European R&D community. In December, an EFGCP Board Meeting endorsed a plan to include Russia in the area of EFGCP influence, and, as a result to establish a trustworthy reputation of Russia as a peer ethical partner among the International Clinical Research Community.
“Being a natural member of European family; de-jure as a formal non-member of EU; and de-facto as a terra incognita for most Europeans, Russia suffers from this triple nature, as a result of ignorance, misinterpretation, and lack of trust and rapport from the European community. We are keen to change this situation,” said Igor Stefanov in that same press release.
For more on the collaboration between SynRG and EFGCP, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
